Related Experiment Video
Updated: May 22, 2026

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
Published on: November 16, 2016
The double-edged role of interferon gamma in cancer immunity
Candelaria Aguilar-García1, Alejandra Martínez-Pérez1, Rocío Granda-Díaz2
1Department of Functional Biology, Immunology, Universidad de Oviedo, Oviedo, Spain; Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Oviedo, Spain; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Abstract:
Interferon-gamma (IFN-γ) is a pivotal cytokine that coordinates the immune response to infections caused by viruses and intracellular pathogens. Knockout (KO) mice lacking IFN-γ exhibited a significant reduction in the capacity of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells to eliminate tumor cells, resulting in accelerated tumor growth and metastasis. These findings underscore the key role of IFN-γ in regulating the antitumor immune response. However, many advanced tumors exhibit dysregulated IFN-γ signaling, which exerts direct protumoral and immunosuppressive effects, thereby allowing cancer cells to evade immune surveillance and promoting cancer progression. This dual role of IFN-γ in regulating cancer immunity has limited its therapeutic use in cancer. Understanding the specific conditions under which IFN-γ has an antitumoral or a protumoral role is a challenge for optimizing its use in cancer therapy.
Insights
Interferon-gamma (IFN-γ) is crucial for anti-tumor immunity, but its dysregulation in advanced cancers promotes tumor growth. Understanding IFN-γ
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Interferon-gamma (IFN-γ) is a key cytokine in coordinating immune responses against viral and intracellular pathogens.
- IFN-γ is essential for the anti-tumor activity of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells.
- Dysregulated IFN-γ signaling in advanced tumors can promote cancer progression and immune evasion.
Purpose of the Study:
- To elucidate the dual role of IFN-γ in cancer immunity.
- To understand the conditions under which IFN-γ exhibits either anti-tumoral or pro-tumoral effects.
- To address challenges in optimizing IFN-γ-based cancer therapies.
Main Methods:
- Utilized knockout (KO) mouse models lacking IFN-γ.
- Assessed the impact of IFN-γ deficiency on tumor cell elimination by CTLs and NK cells.
- Investigated the effects of dysregulated IFN-γ signaling in advanced tumors.
Main Results:
- IFN-γ knockout mice showed reduced CTL and NK cell-mediated tumor cell elimination.
- Lack of IFN-γ led to accelerated tumor growth and metastasis in KO mice.
- Dysregulated IFN-γ signaling in tumors confers protumoral and immunosuppressive functions.
Conclusions:
- IFN-γ plays a critical role in regulating the anti-tumor immune response.
- The dual role of IFN-γ in cancer (anti-tumoral vs. pro-tumoral) complicates its therapeutic application.
- Further research is needed to delineate the specific contexts of IFN-γ's opposing roles for effective cancer therapy.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
